Dr Viranchi Shah on India Pharma Inc’s balancing act between aspirations, expectations and…
Regulatory Watch: Dr Viranchi Shah, spokesperson IDMA, and promotor, Saga Lifesciences
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Viranchi Shah
Revised Schedule M implementation for MSMEs extended, industry welcomes move
The timeline of implementation is extended till December 31, 2025 but pharma MSMEs must file an application with the Central…
The quest for quality continues
It is considerably more difficult to live up to these professed codes of conduct off stage, as it needs to flow right from the…
Manufacturing the right talent
As pharma manufacturing evolves to meet dynamic market demands, regulatory shifts and technological advancements,Kavita Jani…
vriddhi 2024: The Indian pharma industry comes together to deliberate on glorious future
Mehul Shah, Honorary General Secretary, Indian Drug Manufacturers' Association (IDMA) and Managing Director of Encube Ethicals…
CDSCO and IDMA organise ‘Revision of Schedule-M’ workshop in Mumbai
The event witnessed in-person attendance of more than 300 participants and 6,000+ viewers online
Minister of Chemicals and Fertilisers encourages industry to avail Phase II PLI scheme benefits
The scheme will be designed to benefit MSMEs along with large players
Pharma industry appreciates modification in PLI scheme, seek more support
The industry also raises concerns related to brownfield investments, protection of indigenous manufacturing
Industry positive about CDSCO’s move to digitalise regulatory approvals
Stakeholders share suggestions for a smooth transition
NPPA is readying mechanism to ease COVID-19 vaccine supply, prevent unethical practices
The government is in talks with experts and stakeholders to increase access to COVID-19 vaccines, bring down their costs and…